{"id":"W2777724352","doi":"10.1021/acs.molpharmaceut.7b00843","title":"Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"U.S. Army; Natural Sciences and Engineering Research Council of Canada; Ontario Trillium Foundation","keywords":"Olaparib; Ovarian cancer; Serous fluid; Cancer research; PARP inhibitor; Spheroid; Medicine; Paclitaxel; Pharmacology; Doxorubicin; Drug; Cancer; Combination therapy; Poly ADP ribose polymerase; Oncology; Biology; Internal medicine; Chemotherapy; Polymerase; Cell culture; Genetics; DNA","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002020828,0.0002944511,0.0003783667,0.0002986738,0.0001264059,0.0002386281,0.0001725474,0.0002222667,0.0005207543],"category_scores_gemma":[0.00008955799,0.00014178,0.0002773648,0.000248762,0.0001522763,0.0001609953,0.000171549,0.0003876897,0.0001418653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003785567,"about_ca_system_score_gemma":0.0002678567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002259655,"about_ca_topic_score_gemma":0.00480332,"domain_scores_codex":[0.9997692,0.0000747042,0.00002239094,0.00003408371,0.00006795676,0.00003172335],"domain_scores_gemma":[0.9998913,0.00003340478,0.00002258895,0.00001514992,0.00001341692,0.00002407399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001905479,0.00009732132,0.0002585307,0.00005580193,0.000009665015,0.00006977977,0.00003086923,0.0009160673,0.9967659,0.0000791647,0.0001335231,0.001392854],"study_design_scores_gemma":[0.00005111745,0.00156063,0.004984404,0.000007021203,0.00002886905,0.000189066,0.00005743131,0.00583808,0.9840846,0.00004480358,0.003144207,0.000009736045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916693,0.001853837,0.002928513,0.0001416481,0.00005330312,0.00009195331,0.0009314222,0.0000704757,0.002259629],"genre_scores_gemma":[0.9930159,0.001188835,0.0032643,0.00004593399,0.000008112052,0.00008366657,0.0006366592,0.00001459659,0.001741951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002259655,"threshold_uncertainty_score":0.004493058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05005587452836661,"score_gpt":0.3733061430112517,"score_spread":0.3232502684828851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}